The clinical application value of gonadotropin-releasing hormone antagonist combined with low-dose HCG regimen in patients with ovarian hyper-stimulation based on clinical characteristics and laboratory indicators.

Wei, Jiyun; Ban, Ting; Shi, Demin; Mo, Fengming; Wei, Qingmiao; Wei, Lanjing; Qu, Chunfeng

Wei, Jiyun; Ban, Ting; Shi, Demin; Mo, Fengming; Wei, Qingmiao; Wei, Lanjing; Qu, Chunfeng.

Afiliação

Wei J; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.
Ban T; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.
Shi D; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.
Mo F; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.
Wei Q; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.
Wei L; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.
Qu C; Hechi People's Hospital Reproductive Medicine Center Hechi 547000, Guangxi, China.

Am J Transl Res ; 15(8): 5477-5485, 2023.

Article em En | MEDLINE | ID: mdl-37692927

Palavras-chave

Antagonist regimen; clinical outcome; high ovarian response; ovarian hyperstimulation syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transl Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google